Wesseling J - Search Results

1

Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes.

Schmitz AMT, Teixeira SC, Pengel KE, Loo CE, Vogel WV, Wesseling J, Rutgers EJT, Valdés Olmos RA, Sonke GS, Rodenhuis S, Vrancken Peeters MJTFD, Gilhuijs KGA. Schmitz AMT, et al. Among authors: wesseling j. PLoS One. 2017 May 22;12(5):e0176782. doi: 10.1371/journal.pone.0176782. eCollection 2017. PLoS One. 2017. PMID: 28531188 Free PMC article.

2

Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer.

van Westreenen HL, Cobben DC, Jager PL, van Dullemen HM, Wesseling J, Elsinga PH, Plukker JT. van Westreenen HL, et al. Among authors: wesseling j. J Nucl Med. 2005 Mar;46(3):400-4. J Nucl Med. 2005. PMID: 15750150 Free article. Clinical Trial.

3

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).

Bueno-de-Mesquita JM, van Harten WH, Retel VP, van 't Veer LJ, van Dam FS, Karsenberg K, Douma KF, van Tinteren H, Peterse JL, Wesseling J, Wu TS, Atsma D, Rutgers EJ, Brink G, Floore AN, Glas AM, Roumen RM, Bellot FE, van Krimpen C, Rodenhuis S, van de Vijver MJ, Linn SC. Bueno-de-Mesquita JM, et al. Among authors: wesseling j. Lancet Oncol. 2007 Dec;8(12):1079-1087. doi: 10.1016/S1470-2045(07)70346-7. Epub 2007 Nov 26. Lancet Oncol. 2007. PMID: 18042430

4

The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study.

Pengel KE, Loo CE, Teertstra HJ, Muller SH, Wesseling J, Peterse JL, Bartelink H, Rutgers EJ, Gilhuijs KG. Pengel KE, et al. Among authors: wesseling j. Breast Cancer Res Treat. 2009 Jul;116(1):161-9. doi: 10.1007/s10549-008-0182-3. Epub 2008 Sep 21. Breast Cancer Res Treat. 2009. PMID: 18807269 Clinical Trial.

5

[Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy].

Straver ME, van Adrichem JC, Rutgers EJ, Rodenhuis S, Linn SC, Loo CE, Gilhuijs KG, Oldenburg HS, Wesseling J, Russell NS, Antonini N, Vrancken Peeters MT. Straver ME, et al. Among authors: wesseling j. Ned Tijdschr Geneeskd. 2008 Nov 15;152(46):2519-25. Ned Tijdschr Geneeskd. 2008. PMID: 19055260 Dutch.

6

Extensive soft tissue resection with autologous tissue closure for locally recurrent breast cancer: lasting local control and acceptable morbidity.

Aukema TS, Russell NS, Wesseling J, Rutgers EJ. Aukema TS, et al. Among authors: wesseling j. Eur J Surg Oncol. 2009 May;35(5):469-74. doi: 10.1016/j.ejso.2008.12.015. Epub 2009 Jan 26. Eur J Surg Oncol. 2009. PMID: 19176274

7

The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer.

Straver ME, Glas AM, Hannemann J, Wesseling J, van de Vijver MJ, Rutgers EJ, Vrancken Peeters MJ, van Tinteren H, Van't Veer LJ, Rodenhuis S. Straver ME, et al. Among authors: wesseling j. Breast Cancer Res Treat. 2010 Feb;119(3):551-8. doi: 10.1007/s10549-009-0333-1. Epub 2009 Feb 13. Breast Cancer Res Treat. 2010. PMID: 19214742

8

Towards rational axillary treatment in relation to neoadjuvant therapy in breast cancer.

Straver ME, Rutgers EJ, Russell NS, Oldenburg HS, Rodenhuis S, Wesseling J, Vincent A, Peeters MT. Straver ME, et al. Among authors: wesseling j. Eur J Cancer. 2009 Sep;45(13):2284-92. doi: 10.1016/j.ejca.2009.04.029. Epub 2009 May 20. Eur J Cancer. 2009. PMID: 19464164 Clinical Trial.

9

The impact of inter-observer variation in pathological assessment of node-negative breast cancer on clinical risk assessment and patient selection for adjuvant systemic treatment.

Bueno-de-Mesquita JM, Nuyten DS, Wesseling J, van Tinteren H, Linn SC, van de Vijver MJ. Bueno-de-Mesquita JM, et al. Among authors: wesseling j. Ann Oncol. 2010 Jan;21(1):40-7. doi: 10.1093/annonc/mdp273. Epub 2009 Jul 21. Ann Oncol. 2010. PMID: 19622588 Free article.

10

Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response.

de Ronde JJ, Hannemann J, Halfwerk H, Mulder L, Straver ME, Vrancken Peeters MJ, Wesseling J, van de Vijver M, Wessels LF, Rodenhuis S. de Ronde JJ, et al. Among authors: wesseling j. Breast Cancer Res Treat. 2010 Jan;119(1):119-26. doi: 10.1007/s10549-009-0499-6. Epub 2009 Aug 8. Breast Cancer Res Treat. 2010. PMID: 19669409

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

386 results

Search Page

Filters